Home » Technology » Global PET Radiopharmaceuticals Market Will See Strong Expansion Through 2020-2026
Technology

Global PET Radiopharmaceuticals Market Will See Strong Expansion Through 2020-2026

PET Radiopharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PET Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the PET Radiopharmaceuticals market is segmented into
F-18
Ru-82
Others

Segment by Application, the PET Radiopharmaceuticals market is segmented into
Oncology
Cardiology
Neurology
Others

To Get Sample Copy of Report [email protected] https://www.researchmoz.us/enquiry.php?type=S&repid=2726439

Regional and Country-level Analysis
The PET Radiopharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the PET Radiopharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and PET Radiopharmaceuticals Market Share Analysis
PET Radiopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in PET Radiopharmaceuticals business, the date to enter into the PET Radiopharmaceuticals market, PET Radiopharmaceuticals product introduction, recent developments, etc.

The major vendors covered:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)

Enquiry For Discount [email protected] https://www.researchmoz.us/enquiry.php?type=D&repid=2726439

 

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfil all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organisations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

ResearchMoz

Mr. Rohit Bhisey,

Tel: +1-518-621-2074

USA-Canada Toll Free: 866-997-4948

Email: [email protected]

Website:https://www.researchmoz.us/

Visitor Statistics